Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00975455 · ClinicalTrials.gov registry record
Hematuria Evaluation Trial for Subjects With Microscopic or Gross Hematuria to Determine the Absence or Presence of Bladder Cancer
A clinical trial of Microscopic or Gross Hematuria, sponsored by Predictive Biosciences.
- Completed
- Registry status
- 1,400
- Enrollment target
- 13
- Study locations
NCT00975455 is a study of Microscopic or Gross Hematuria that has completed, run by Predictive Biosciences. The registered enrollment target is 1,400 participants. The trial reports 13 study locations across 9 states.
The verdict
NCT00975455, a study of Microscopic or Gross Hematuria, has completed, sponsored by Predictive Biosciences.
- COMPLETED
- Registry status
- 1,400 participants
- Enrollment target
- 13
- Study locations
Study Summary
The purpose of the study is to evaluate subjects with gross or microscopic hematuria undergoing scheduled cystoscopy to determine the absence or presence of bladder cancer.
Conditions Studied
Study Locations (13)
Florida
- Atlantic Urological Associates - Daytona Beach
- Winter Park Urology - Orlando
New Jersey
- Coastal Urology Associates - Brick
- Associates in Urology - Orange
New York
- Community Care Physicians - Albany
- Hudson Valley Urology - Poughkeepsie
Texas
- Urology Clinics of North Texas - Dallas
- Urology San Antonio Research - San Antonio
Indiana
- Metropolitan Urology - Jeffersonville
Minnesota
- Mayo Validation Support Services - Rochester
North Carolina
- Eastern Urological Associates - Greenville
Ohio
- The Urology Group - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,400 participants |
| Start Date | 2009-07 |
| Est. Completion | 2011-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00975455
The ClinicalTrials.gov registry entry for NCT00975455 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,400 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Predictive Biosciences, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Microscopic or Gross Hematuria appearing as the primary indexed condition, and to 0 interventions.
NCT00975455 reports 13 study locations spanning 9 distinct geographic areas - top geographies include Florida, New Jersey, New York.
Frequently Asked Questions
What is clinical trial NCT00975455 about?
NCT00975455 is a clinical study titled "Hematuria Evaluation Trial for Subjects With Microscopic or Gross Hematuria to Determine the Absence or Presence of Bladder Cancer". The purpose of the study is to evaluate subjects with gross or microscopic hematuria undergoing scheduled cystoscopy to determine the absence or presence of bladder cancer.
What is the current status of trial NCT00975455?
This trial is currently completed. The enrollment target is 1,400 participants. The study started on 2009-07. Estimated completion is 2011-01.
What conditions does trial NCT00975455 study?
This clinical trial studies the following conditions: Microscopic or Gross Hematuria.
Who is sponsoring clinical trial NCT00975455?
This trial is sponsored by Predictive Biosciences, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00975455 being conducted?
This trial has 13 study locations across Florida, Indiana, Minnesota, New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.